Repeatability of AI-based, automatic measurement of vertebral and cardiovascular imaging biomarkers in low-dose chest CT: the ImaLife cohort
摘要
To evaluate the repeatability of AI-based automatic measurement of vertebral and cardiovascular markers on low-dose chest CT.
MethodsWe included participants of the population-based Imaging in Lifelines (ImaLife) study with low-dose chest CT at baseline and 3–4 month follow-up. An AI system (AI-Rad Companion chest CT prototype) performed automatic segmentation and quantification of vertebral height and density, aortic diameters, heart volume (cardiac chambers plus pericardial fat), and coronary artery calcium volume (CACV). A trained researcher visually checked segmentation accuracy. We evaluated the repeatability of adequate AI-based measurements at baseline and repeat scan using Intraclass Correlation Coefficient (ICC), relative differences, and change in CACV risk categorization, assuming no physiological change.
ResultsOverall, 632 participants (63 ± 11 years; 56.6% men) underwent short-term repeat CT (mean interval, 3.9 ± 1.8 months). Visual assessment showed adequate segmentation in both baseline and repeat scan for 98.7% of vertebral measurements, 80.1–99.4% of aortic measurements (except for the sinotubular junction (65.2%)), and 86.0% of CACV. For heart volume, 53.5% of segmentations were adequate at baseline and repeat scans. ICC for adequately segmented cases showed excellent agreement for all biomarkers (ICC > 0.9). Relative difference between baseline and repeat measurements was < 4% for vertebral and aortic measurements, 7.5% for heart volume, and 28.5% for CACV. There was high concordance in CACV risk categorization (81.2%).
ConclusionIn low-dose chest CT, segmentation accuracy of AI-based software was high for vertebral, aortic, and CACV evaluation and relatively low for heart volume. There was excellent repeatability of vertebral and aortic measurements and high concordance in overall CACV risk categorization.
Key Points